Friday, November 6, 2026
BTC $75,854 ▼ 4.90%
Subscribe
Menu
NewsLive WirePoliticsWorldMarketsDigital AssetsTechnologySports
FranchisesThe BriefThe Big ReadThe BreakdownCrypto Culture
MoreDeFi & On-ChainU.S. EquitiesMacro & RatesResearch
LIVE
BTC$75,854down−4.90%ETH$2,236down−6.45%SOL$90.30down−5.35%XRP$1.19down−9.33%LINK$10.88down−4.75%ADA$0.187down−4.03%S&P 5007,354down−4.36%Nasdaq24,315down−5.52%Dow51,523down−3.44%RUT2,730down−4.45%TNX4.88%up+0.85%TYX5.29%up+0.70%FVX4.66%up+1.04%IRX4.00%up+0.28%VIX27.04down−4.05%GOLD$4,057.00down−1.37%SILVER$51.95down−0.82%OIL$91.18up+0.73%DXY102.21up+0.65%NVDA$181.60down−9.26%AAPL$344.17down−1.53%TSLA$343.69down−10.77%META$605.08down−3.96%MSFT$535.93down−3.58%AMZN$260.21down−2.19%GOOGL$282.57down−2.20%Fear & Greed28 — FearBTC$75,854down−4.90%ETH$2,236down−6.45%SOL$90.30down−5.35%XRP$1.19down−9.33%LINK$10.88down−4.75%ADA$0.187down−4.03%S&P 5007,354down−4.36%Nasdaq24,315down−5.52%Dow51,523down−3.44%RUT2,730down−4.45%TNX4.88%up+0.85%TYX5.29%up+0.70%FVX4.66%up+1.04%IRX4.00%up+0.28%VIX27.04down−4.05%GOLD$4,057.00down−1.37%SILVER$51.95down−0.82%OIL$91.18up+0.73%DXY102.21up+0.65%NVDA$181.60down−9.26%AAPL$344.17down−1.53%TSLA$343.69down−10.77%META$605.08down−3.96%MSFT$535.93down−3.58%AMZN$260.21down−2.19%GOOGL$282.57down−2.20%Fear & Greed28 — Fear
Tag

cancer screening

1 article

Jefferies Initiates Freenome With Buy, Sees 47% Upside in Cancer Screening
U.S. Equities80d ago
Jefferies Initiates Freenome With Buy, Sees 47% Upside in Cancer Screening
Jefferies set a $17 price target on Freenome (FRNM), trading at $11.56, citing the company's cancer screening potential as the core catalyst